Our Prospan brand is backed by data from more than 65,000 patients. These also include clinical studies that – in accordance with the latest scientific knowledge – confirm that our cough medicine is not only outstanding in terms of tolerability, but also entirely convincing in every respect with regard to its efficacy.
This reflects our commitment to delivering responsible medicine.
For this reason, our investments in research programmes for our products are above the average for our industry and we conduct clinical tests in compliance with the highest quality standards. The results show why are products are verifiably considered the best in their class and why they are included in evidence-based treatment recommendations.
But we go one step further. For instance, with our exhaustive, pre-clinical investigations to decipher the therapeutic mechanism of the active substance from ivy leaves in Prospan we have set standards for the rational phytotherapy of respiratory complaints and a historic milestone in the field of herbal medicine research.
As an independent, medium-sized, family owned and managed company, we take particularly pride in this.
Because, we are fully aware of the importance of our brands and the responsibility they bear.